Global wearable and connected medical technology market

The global market for wearable medical technology is projected to expand significantly, with estimates suggesting it could grow from USD 3.98 billion in 2026 to USD 9.97 billion by 2031, representing a compound annual growth rate of 20.2%. This sector includes continuous glucose monitors, wearable drug delivery systems, smart patches, and neuro-stimulators used for chronic disease management and post-surgical care. Growth is driven by the rising prevalence of cardiovascular disorders and diabetes, alongside increased demand for remote patient monitoring and home-based care.

Specific segments within the connected home medical monitoring market are also seeing substantial growth. Berg Insight forecasts that the number of such devices—specifically those used in mHealth care programs—will reach approximately 159.7 million units by 2030, up from 92.7 million in 2025. Key applications include sleep therapy, diabetes management, and the remote monitoring of implantable cardiac rhythm management (CRM) devices. Sleep therapy remains the largest segment, while diabetes management is the second-largest, driven by companies such as Abbott, Dexcom, and Insulet.

The digital diabetes management market specifically is expected to rise from $19.2 billion in 2025 to $58.1 billion by 2030. A landmark development in this sector is the FDA approval of the world’s first fully implantable continuous glucose monitoring (CGM) sensor capable of 365-day use. While technological integration of AI, IoT, and 5G facilitates real-time diagnostics, the industry continues to navigate challenges related to high device costs, regulatory requirements, data privacy, and questions regarding the accuracy and validation of longitudinal data.